Kinetic characterization of hypophosphatasia mutations with physiological substrates

Detalhes bibliográficos
Autor(a) principal: Di Mauro, S.
Data de Publicação: 2002
Outros Autores: Manes, T., Hessle, L., Kozlenkov, A., Pizauro, J. M., Hoylaerts, M. F., Millan, J. L.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1359/jbmr.2002.17.8.1383
http://hdl.handle.net/11449/37990
Resumo: We have analyzed 16 missense mutations of the tissue-nonspecific AP (TNAP) gene found in patients with hypophosphatasia. These mutations span the phenotypic spectrum of the disease, from the lethal perinatal/infantile forms to the less severe adult and odontohypophosphatasia. Site-directed mutagenesis was used to introduce a sequence tag into the TNAP cDNA and eliminate the glycosylphosphatidylinositol (GPI)-anchor recognition sequence to produce a secreted epitope-tagged TNAP (setTNAP). The properties of GPI-anchored TNAP (gpiTNAP) and setTNAP were found comparable. After introducing each single hypophosphatasia mutation, the setTNAP and mutant TNAP cDNAs were expressed in COS-1 cells and the recombinant flagged enzymes were affinity purified. We characterized the kinetic behavior, inhibition, and heat stability properties of each mutant using the artificial substrate p-nitrophenylphosphate (pNPP) at pH 9.8. We also determined the ability of the mutants to metabolize two natural substrates of TNAP, that is, pyridoxal-5'-phosphate (PLP) and inorganic pyrophosphate (PPi), at physiological pH. Six of the mutant enzymes were completely devoid of catalytic activity (R54C, R54P, A94T, R206W, G317D, and V365I), and 10 others (A16V, A115V, A160T, A162T, E174K, E174G, D277A, E281K, D361V, and G439R) showed various levels of residual activity. The A160T substitution was found to decrease the catalytic efficiency of the mutant enzyme toward pNPP to retain normal activity toward PPi and to display increased activity toward PLP. The A162T substitution caused a considerable reduction in the pNPPase, PPiase, and PLPase activities of the mutant enzyme. The D277A mutant was found to maintain high catalytic efficiency toward pNPP as substrate but not against PLP or PPi. Three mutations ( E174G, E174K, and E281K) were found to retain normal or slightly subnormal catalytic efficiency toward pNPP and PPi but not against PLP. Because abnormalities in PLP metabolism have been shown to cause epileptic seizures in mice null for the TNAP gene, these kinetic data help explain the variable expressivity of epileptic seizures in hypophosphatasia patients.
id UNSP_0d0064c94a80f8ef7454bda3177a2ed0
oai_identifier_str oai:repositorio.unesp.br:11449/37990
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Kinetic characterization of hypophosphatasia mutations with physiological substratesgenetic diseasemissense mutationscatalytic efficiencynatural substratesalkaline phosphataseWe have analyzed 16 missense mutations of the tissue-nonspecific AP (TNAP) gene found in patients with hypophosphatasia. These mutations span the phenotypic spectrum of the disease, from the lethal perinatal/infantile forms to the less severe adult and odontohypophosphatasia. Site-directed mutagenesis was used to introduce a sequence tag into the TNAP cDNA and eliminate the glycosylphosphatidylinositol (GPI)-anchor recognition sequence to produce a secreted epitope-tagged TNAP (setTNAP). The properties of GPI-anchored TNAP (gpiTNAP) and setTNAP were found comparable. After introducing each single hypophosphatasia mutation, the setTNAP and mutant TNAP cDNAs were expressed in COS-1 cells and the recombinant flagged enzymes were affinity purified. We characterized the kinetic behavior, inhibition, and heat stability properties of each mutant using the artificial substrate p-nitrophenylphosphate (pNPP) at pH 9.8. We also determined the ability of the mutants to metabolize two natural substrates of TNAP, that is, pyridoxal-5'-phosphate (PLP) and inorganic pyrophosphate (PPi), at physiological pH. Six of the mutant enzymes were completely devoid of catalytic activity (R54C, R54P, A94T, R206W, G317D, and V365I), and 10 others (A16V, A115V, A160T, A162T, E174K, E174G, D277A, E281K, D361V, and G439R) showed various levels of residual activity. The A160T substitution was found to decrease the catalytic efficiency of the mutant enzyme toward pNPP to retain normal activity toward PPi and to display increased activity toward PLP. The A162T substitution caused a considerable reduction in the pNPPase, PPiase, and PLPase activities of the mutant enzyme. The D277A mutant was found to maintain high catalytic efficiency toward pNPP as substrate but not against PLP or PPi. Three mutations ( E174G, E174K, and E281K) were found to retain normal or slightly subnormal catalytic efficiency toward pNPP and PPi but not against PLP. Because abnormalities in PLP metabolism have been shown to cause epileptic seizures in mice null for the TNAP gene, these kinetic data help explain the variable expressivity of epileptic seizures in hypophosphatasia patients.Burnham Inst, La Jolla, CA 92037 USAUNESP, Fac Ciências Agrarias & Vet, São Paulo, BrazilUniv Leuven, Ctr Mol & Vasc Biol, Louvain, BelgiumUmea Univ, Dept Med Genet, Umea, SwedenUNESP, Fac Ciências Agrarias & Vet, São Paulo, BrazilAmer Soc Bone & Mineral ResBurnham InstUniversidade Estadual Paulista (Unesp)Univ LeuvenUmea UnivDi Mauro, S.Manes, T.Hessle, L.Kozlenkov, A.Pizauro, J. M.Hoylaerts, M. F.Millan, J. L.2014-05-20T15:28:06Z2014-05-20T15:28:06Z2002-08-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article1383-1391application/pdfhttp://dx.doi.org/10.1359/jbmr.2002.17.8.1383Journal of Bone and Mineral Research. Washington: Amer Soc Bone & Mineral Res, v. 17, n. 8, p. 1383-1391, 2002.0884-0431http://hdl.handle.net/11449/3799010.1359/jbmr.2002.17.8.1383WOS:000177048900006WOS000177048900006.pdfWeb of Sciencereponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengJournal of Bone and Mineral Research6.3142,808info:eu-repo/semantics/openAccess2023-11-05T06:13:23Zoai:repositorio.unesp.br:11449/37990Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T16:59:49.720214Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Kinetic characterization of hypophosphatasia mutations with physiological substrates
title Kinetic characterization of hypophosphatasia mutations with physiological substrates
spellingShingle Kinetic characterization of hypophosphatasia mutations with physiological substrates
Di Mauro, S.
genetic disease
missense mutations
catalytic efficiency
natural substrates
alkaline phosphatase
title_short Kinetic characterization of hypophosphatasia mutations with physiological substrates
title_full Kinetic characterization of hypophosphatasia mutations with physiological substrates
title_fullStr Kinetic characterization of hypophosphatasia mutations with physiological substrates
title_full_unstemmed Kinetic characterization of hypophosphatasia mutations with physiological substrates
title_sort Kinetic characterization of hypophosphatasia mutations with physiological substrates
author Di Mauro, S.
author_facet Di Mauro, S.
Manes, T.
Hessle, L.
Kozlenkov, A.
Pizauro, J. M.
Hoylaerts, M. F.
Millan, J. L.
author_role author
author2 Manes, T.
Hessle, L.
Kozlenkov, A.
Pizauro, J. M.
Hoylaerts, M. F.
Millan, J. L.
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv Burnham Inst
Universidade Estadual Paulista (Unesp)
Univ Leuven
Umea Univ
dc.contributor.author.fl_str_mv Di Mauro, S.
Manes, T.
Hessle, L.
Kozlenkov, A.
Pizauro, J. M.
Hoylaerts, M. F.
Millan, J. L.
dc.subject.por.fl_str_mv genetic disease
missense mutations
catalytic efficiency
natural substrates
alkaline phosphatase
topic genetic disease
missense mutations
catalytic efficiency
natural substrates
alkaline phosphatase
description We have analyzed 16 missense mutations of the tissue-nonspecific AP (TNAP) gene found in patients with hypophosphatasia. These mutations span the phenotypic spectrum of the disease, from the lethal perinatal/infantile forms to the less severe adult and odontohypophosphatasia. Site-directed mutagenesis was used to introduce a sequence tag into the TNAP cDNA and eliminate the glycosylphosphatidylinositol (GPI)-anchor recognition sequence to produce a secreted epitope-tagged TNAP (setTNAP). The properties of GPI-anchored TNAP (gpiTNAP) and setTNAP were found comparable. After introducing each single hypophosphatasia mutation, the setTNAP and mutant TNAP cDNAs were expressed in COS-1 cells and the recombinant flagged enzymes were affinity purified. We characterized the kinetic behavior, inhibition, and heat stability properties of each mutant using the artificial substrate p-nitrophenylphosphate (pNPP) at pH 9.8. We also determined the ability of the mutants to metabolize two natural substrates of TNAP, that is, pyridoxal-5'-phosphate (PLP) and inorganic pyrophosphate (PPi), at physiological pH. Six of the mutant enzymes were completely devoid of catalytic activity (R54C, R54P, A94T, R206W, G317D, and V365I), and 10 others (A16V, A115V, A160T, A162T, E174K, E174G, D277A, E281K, D361V, and G439R) showed various levels of residual activity. The A160T substitution was found to decrease the catalytic efficiency of the mutant enzyme toward pNPP to retain normal activity toward PPi and to display increased activity toward PLP. The A162T substitution caused a considerable reduction in the pNPPase, PPiase, and PLPase activities of the mutant enzyme. The D277A mutant was found to maintain high catalytic efficiency toward pNPP as substrate but not against PLP or PPi. Three mutations ( E174G, E174K, and E281K) were found to retain normal or slightly subnormal catalytic efficiency toward pNPP and PPi but not against PLP. Because abnormalities in PLP metabolism have been shown to cause epileptic seizures in mice null for the TNAP gene, these kinetic data help explain the variable expressivity of epileptic seizures in hypophosphatasia patients.
publishDate 2002
dc.date.none.fl_str_mv 2002-08-01
2014-05-20T15:28:06Z
2014-05-20T15:28:06Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1359/jbmr.2002.17.8.1383
Journal of Bone and Mineral Research. Washington: Amer Soc Bone & Mineral Res, v. 17, n. 8, p. 1383-1391, 2002.
0884-0431
http://hdl.handle.net/11449/37990
10.1359/jbmr.2002.17.8.1383
WOS:000177048900006
WOS000177048900006.pdf
url http://dx.doi.org/10.1359/jbmr.2002.17.8.1383
http://hdl.handle.net/11449/37990
identifier_str_mv Journal of Bone and Mineral Research. Washington: Amer Soc Bone & Mineral Res, v. 17, n. 8, p. 1383-1391, 2002.
0884-0431
10.1359/jbmr.2002.17.8.1383
WOS:000177048900006
WOS000177048900006.pdf
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Journal of Bone and Mineral Research
6.314
2,808
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 1383-1391
application/pdf
dc.publisher.none.fl_str_mv Amer Soc Bone & Mineral Res
publisher.none.fl_str_mv Amer Soc Bone & Mineral Res
dc.source.none.fl_str_mv Web of Science
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1808128733509320704